News | April 23, 2026
AbbVie bets $1.4B on North Carolina pharma mega-campus
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
Sanplatec is leading the industry in the field of containers and devices for cell culture and live transport
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
Move comes amid rising regulatory pressures
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
The plant is currently scaling towards a production capacity of nearly 3 million gloves per day
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents
Subscribe To Our Newsletter & Stay Updated
